The Latest Breaking News from McKesson

With McKesson gearing up to release its first-quarter earnings next month, analysts project a single-digit earnings dip.

McKesson (MCK) reported consistent revenue growth and solid profit margins in the last reported quarter, supported by robust demand for pharmaceuticals and medical supplies and efficient cost management. With nearly 25% year-to-date gains, should you invest in this healthcare stock? Read on to learn more….

Are you looking for probiotics to boost your emotional well-being? Explore our curated list of the top 13 mood probiotics known for enhancing digestion and promoting brain health.

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

Unlock the gates of wellness with these breakout healthcare stocks.

Laura Bray couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.

The Chart of the Day belongs to the healthcare company McKesson (MCK) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

McKesson took a drubbing for its role in shipping obscene quantities of opioids to the most addicted corners of America.

Mckesson Corporation (MCK) delivered better-than-expected earnings for the last quarter and updated its outlook for fiscal 2023. Wall Street analysts expect the stock to rise more than 18% in the near term. Therefore, it could be wise to buy this medical stock now. Read more….